IP
CRDF icon

Intellectus Partners’s Cardiff Oncology CRDF Stock Holding History

Intellectus Partners’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28
Closed – – 304
2018
Q3 		$0 Buy
+28
New +$133 ﹤0.01% 579
2018
Q2 		– Sell
-28
Closed -$1K – 590
2018
Q1 		$1K Hold
28
– – ﹤0.01% 579
2017
Q4 		$1K Hold
28
– – ﹤0.01% 593
2017
Q3 		$1K Hold
28
– – ﹤0.01% 751
2017
Q2 		$3K Hold
28
– – ﹤0.01% 701
2017
Q1 		$2K Hold
28
– – ﹤0.01% 656
2016
Q4 		$4K Buy
+28
New +$6.54K ﹤0.01% 615

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return